Western Australian Consolidated Regulations Western Australian Consolidated Regulations (1) A medical
practitioner shall not supply flunitrazepam or issue, write or authorise a
prescription for flunitrazepam for a person unless that practitioner has been
authorised in writing to do so in relation to that particular person by the
CEO.
(2) The CEO shall give
the authorisation an identifying number (in this regulation called the HDWA
Authorisation No. ).
(3) In an
authorisation given under subregulation (1), the CEO may specify that any
one or more of the conditions and restrictions set out below apply,
namely —
(a) that
the prescription be issued by or the treatment be administered by the medical
practitioner specified in the authorisation;
(b) that
the amount of flunitrazepam to be prescribed or used for treatment shall not
exceed the amount specified;
(c) that
the amount of flunitrazepam to be prescribed or used on any one day shall not
exceed the amount specified;
(d) that
the concentration of flunitrazepam to be prescribed shall not exceed the
concentration specified;
(e) that
the intervals between the issue of prescriptions for flunitrazepam or the
administration of flunitrazepam shall be such as are specified;
(f) that
the prescription be supplied at the pharmacy specified;
(g) that
the amount of flunitrazepam dispensed on a single prescription not exceed such
amount as is specified;
(h) that
the amount of flunitrazepam that may be supplied on any one day shall not
exceed such amount as is specified.
(4) An authorisation
issued for the purpose of subregulation (1) is valid for such period as
is specified by the CEO unless revoked by the CEO, by notice in writing served
on the practitioner, before the expiration of that period.
(5) The CEO may at any
time, by notice in writing served on the practitioner, amend the conditions
and restrictions specified under subregulation (3).
(6) A medical
practitioner shall not supply flunitrazepam or issue, write or authorise a
prescription for flunitrazepam contrary to any conditions and restrictions
specified in the authorisation.
(7) A medical
practitioner who issues or writes a prescription for flunitrazepam shall write
the HDWA Authorisation No. on the prescription after his or her signature
using the following format —
“HDWA
Authorisation No. .................”.
(8) A pharmacist shall
not sell or supply flunitrazepam unless the HDWA Authorisation No. is written
on the prescription for the flunitrazepam in accordance with
subregulation (7).
[Regulation 51GB inserted in Gazette
26 May 1998 p. 2966; amended in Gazette 15 Dec 2006
p. 5630; 21 Apr 2009 p. 1366; 1 Oct 2010
p. 5079‑80.]